SLC5A2 and heart failure: However, their core renal and cardiovascular actions are fundamentally similar, with both demonstrating efficacy in glycemic control and heart failure management across diverse patient populations At a mechanistic level, SGLT2 inhibitors exert multi-organ effects beyond glycemic control.